Happy Friday! Before you head out for the weekend, check out your legal news headlines from Thomson Reuters News and Insight. Brand drug ‘product hopping’ comes under scrutiny In the latest effort to level the playing field for generics, the FTC has stepped up scrutiny of brand-name drugmakers that tweak medications to stay ahead of …
